EMFACE® can be performed following hyaluronic acid treatments; however, it is essential to allow sufficient time between treatments and for the patient to be assessed on an individual basis by a specialist.

Hyaluronic acid is responsible for restoring tissue volume, whilst EMFACE® targets the muscles and skin quality, enabling a comprehensive approach to facial rejuvenation.

The key benefits include EMFACE® following hyaluronic acid treatment, safe combination of aesthetic treatments and comprehensive improvement of the facial contour, which together enhance the effectiveness of anti-ageing treatments.

In practice, EMFACE® is often scheduled as a primary treatment or carried out once the effects of dermal fillers have stabilised, in order to avoid any interference between the two methods.